Position in MRK
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$3,163,798
+$192,034 QoQ
Shares Held
24,621
-0.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#1,305
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pekin Hardy Strauss, Inc. holds $25,845,902 across 12 Drug Manufacturers - General names. MRK ranks #5 (12.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
28,681 | $7,217,286 | |
| 2 | NVS |
Novartis AG
|
26,136 | $4,096,033 | |
| 3 | JNJ |
Johnson & Johnson
|
13,995 | $3,554,310 | |
| 4 | NVO |
Novo Nordisk A S
|
70,160 | $3,363,470 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
24,621 | $3,163,798 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
23,721 | $1,366,804 | |
| 7 | LLY |
ELI LILLY & Co
|
971 | $1,164,646 | |
| 8 | AZN |
Astrazeneca PLC
|
3,262 | $618,540 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,163,798 | 24,621 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $2,971,764 | 24,705 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $2,721,286 | 25,853 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $1,710,073 | 20,375 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,745,873 | 22,055 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $4,394,290 | 48,956 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $5,009,613 | 50,358 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $6,674,261 | 58,773 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $7,401,506 | 59,786 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $7,962,654 | 60,346 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $6,679,328 | 61,267 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $6,319,997 | 61,389 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $7,515,581 | 65,132 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $7,078,871 | 66,537 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $7,668,309 | 69,115 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $5,933,754 | 68,901 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $6,079,489 | 66,683 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $5,377,474 | 65,539 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,980,910 | 64,991 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $4,756,490 | 63,327 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,876,801 | 62,708 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $4,662,482 | 60,481 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $4,795,522 | 58,625 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $4,877,794 | 58,804 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $4,469,366 | 57,796 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $4,416,046 | 57,396 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||